152 related articles for article (PubMed ID: 31688603)
1. Expression of Epithelial-Mesenchymal Transition Markers in Treated Pancreatic Ductal Adenocarcinoma.
Wang M; Estrella JS; Katz MH; Kim M; Rashid A; Lee JE; Maitra A; Wistuba II; Wolff RA; Varadhachary GR; Wang H
Pancreas; 2019; 48(10):1367-1372. PubMed ID: 31688603
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of Zinc finger E-box binding homeobox 1 (ZEB1) expression in cancer cells and cancer-associated fibroblasts in pancreatic head cancer.
Bronsert P; Kohler I; Timme S; Kiefer S; Werner M; Schilling O; Vashist Y; Makowiec F; Brabletz T; Hopt UT; Bausch D; Kulemann B; Keck T; Wellner UF
Surgery; 2014 Jul; 156(1):97-108. PubMed ID: 24929761
[TBL] [Abstract][Full Text] [Related]
3. Epithelial-to-mesenchymal transition (EMT) in intraductal papillary mucinous neoplasm (IPMN) is associated with high tumor grade and adverse outcomes.
Lahat G; Lubezky N; Loewenstein S; Nizri E; Gan S; Pasmanik-Chor M; Hayman L; Barazowsky E; Ben-Haim M; Klausner JM
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S750-7. PubMed ID: 25069861
[TBL] [Abstract][Full Text] [Related]
4. Epithelial-mesenchymal transition and mesenchymal-epithelial transition via regulation of ZEB-1 and ZEB-2 expression in pancreatic cancer.
Kurahara H; Takao S; Maemura K; Mataki Y; Kuwahata T; Maeda K; Ding Q; Sakoda M; Iino S; Ishigami S; Ueno S; Shinchi H; Natsugoe S
J Surg Oncol; 2012 Jun; 105(7):655-61. PubMed ID: 22213144
[TBL] [Abstract][Full Text] [Related]
5. Detailed analysis of epithelial-mesenchymal transition and tumor budding identifies predictors of long-term survival in pancreatic ductal adenocarcinoma.
Kohler I; Bronsert P; Timme S; Werner M; Brabletz T; Hopt UT; Schilling O; Bausch D; Keck T; Wellner UF
J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 1():78-84. PubMed ID: 25827809
[TBL] [Abstract][Full Text] [Related]
6. CIP2A expression is associated with altered expression of epithelial-mesenchymal transition markers and predictive of poor prognosis in pancreatic ductal adenocarcinoma.
Wang L; Gu F; Ma N; Zhang L; Bian JM; Cao HY
Tumour Biol; 2013 Aug; 34(4):2309-13. PubMed ID: 23568706
[TBL] [Abstract][Full Text] [Related]
7. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of epithelial-mesenchymal transition markers in prostate cancer.
Figiel S; Vasseur C; Bruyere F; Rozet F; Maheo K; Fromont G
Hum Pathol; 2017 Mar; 61():26-32. PubMed ID: 27818287
[TBL] [Abstract][Full Text] [Related]
9. Deregulated expression of miR-107 inhibits metastasis of PDAC through inhibition PI3K/Akt signaling via caveolin-1 and PTEN.
Xiong J; Wang D; Wei A; Lu H; Tan C; Li A; Tang J; Wang Y; He S; Liu X; Hu W
Exp Cell Res; 2017 Dec; 361(2):316-323. PubMed ID: 29111166
[TBL] [Abstract][Full Text] [Related]
10. Vimentin Expression in Tumor Microenvironment Predicts Survival in Pancreatic Ductal Adenocarcinoma: Heterogeneity in Fibroblast Population.
Maehira H; Miyake T; Iida H; Tokuda A; Mori H; Yasukawa D; Mukaisho KI; Shimizu T; Tani M
Ann Surg Oncol; 2019 Dec; 26(13):4791-4804. PubMed ID: 31583548
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of homeobox B-13 correlates with angiogenesis, aberrant expression of EMT markers, aggressive characteristics and poor prognosis in pancreatic carcinoma.
Zhai LL; Wu Y; Cai CY; Tang ZG
Int J Clin Exp Pathol; 2015; 8(6):6919-27. PubMed ID: 26261579
[TBL] [Abstract][Full Text] [Related]
12. Epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma and pancreatic tumor cell lines: the role of neutrophils and neutrophil-derived elastase.
Grosse-Steffen T; Giese T; Giese N; Longerich T; Schirmacher P; Hänsch GM; Gaida MM
Clin Dev Immunol; 2012; 2012():720768. PubMed ID: 23227088
[TBL] [Abstract][Full Text] [Related]
13. Epithelial-mesenchymal transition (EMT) and activated extracellular signal-regulated kinase (p-Erk) in surgically resected pancreatic cancer.
Javle MM; Gibbs JF; Iwata KK; Pak Y; Rutledge P; Yu J; Black JD; Tan D; Khoury T
Ann Surg Oncol; 2007 Dec; 14(12):3527-33. PubMed ID: 17879119
[TBL] [Abstract][Full Text] [Related]
14. Upregulated SMAD3 promotes epithelial-mesenchymal transition and predicts poor prognosis in pancreatic ductal adenocarcinoma.
Yamazaki K; Masugi Y; Effendi K; Tsujikawa H; Hiraoka N; Kitago M; Shinoda M; Itano O; Tanabe M; Kitagawa Y; Sakamoto M
Lab Invest; 2014 Jun; 94(6):683-91. PubMed ID: 24709776
[TBL] [Abstract][Full Text] [Related]
15. High expression of both desmoplastic stroma and epithelial to mesenchymal transition markers associate with shorter survival in pancreatic ductal adenocarcinoma.
Sánchez-Ramírez D; Medrano-Guzmán R; Candanedo-González F; De Anda-González J; García-Rios LE; Pérez-Koldenkova V; Gutiérrez-de la Barrera M; Rodríguez-Enríquez S; Velasco-Velázquez M; Pacheco-Velázquez SC; Piña-Sánchez P; Mayani H; Gómez-Delgado A; Monroy-García A; Martínez-Lara AK; Montesinos JJ
Eur J Histochem; 2022 Feb; 66(1):. PubMed ID: 35174683
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal-epithelial transition of pancreatic cancer cells at perineural invasion sites is induced by Schwann cells.
Fujii-Nishimura Y; Yamazaki K; Masugi Y; Douguchi J; Kurebayashi Y; Kubota N; Ojima H; Kitago M; Shinoda M; Hashiguchi A; Sakamoto M
Pathol Int; 2018 Apr; 68(4):214-223. PubMed ID: 29457853
[TBL] [Abstract][Full Text] [Related]
17. Epithelial-Mesenchymal Transition Predicts Survival in Oral Squamous Cell Carcinoma.
Wangmo C; Charoen N; Jantharapattana K; Dechaphunkul A; Thongsuksai P
Pathol Oncol Res; 2020 Jul; 26(3):1511-1518. PubMed ID: 31471883
[TBL] [Abstract][Full Text] [Related]
18. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
19. The ambiguous role of microRNA-205 and its clinical potential in pancreatic ductal adenocarcinoma.
Michael Traeger M; Rehkaemper J; Ullerich H; Steinestel K; Wardelmann E; Senninger N; Abdallah Dhayat S
J Cancer Res Clin Oncol; 2018 Dec; 144(12):2419-2431. PubMed ID: 30244390
[TBL] [Abstract][Full Text] [Related]
20. CD24 and S100A4 expression in resectable pancreatic cancers with earlier disease recurrence and poor survival.
Lee SH; Kim H; Hwang JH; Shin E; Lee HS; Hwang DW; Cho JY; Yoon YS; Han HS; Cha BH
Pancreas; 2014 Apr; 43(3):380-8. PubMed ID: 24622067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
